Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)
Clinical trial NCT06874933 · RECRUITING
Trial details
- NCT number
- NCT06874933
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-04
- Primary completion
- 2027-04-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.